FDA Inspection 1042777 — Surmasis Pharmaceutical, LLC
The FDA completed an inspection of Surmasis Pharmaceutical, LLC on Mar 1, 2018 in Des Moines, IA. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Mar 1, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Des Moines, IA (United States)